Top

BMC Neurology

Published in:

Open Access 01-12-2022 | Stroke | Research

Association of blood eicosapentaenoic acid levels with intracerebral hemorrhage during the COVID-19 pandemic: preliminary experience from a single-center in Japan

Authors: Kenichiro Hira, Yuji Ueno, Nobukazu Miyamoto, Sho Nakajima, Chikage Kijima, Nobutaka Hattori

Published in: BMC Neurology | Issue 1/2022

Abstract

Background

The COVID-19 pandemic has forced lockdowns and declarations of states of emergency, resulting in marked changes to daily life such as dietary habits in many countries. Though serum omega-3 polyunsaturated fatty acids levels have been shown to be useful markers for recurrent vascular events or worse prognosis in cardiovascular diseases and ischemic stroke, the relationship between serum omega-3 PUFA levels and the occurrence of intracerebral hemorrhage has essentially been unknown. We explored the association of serum omega-3 polyunsaturated fatty acids with intracerebral hemorrhage during the COVID-19 pandemic.

Methods

Participants comprised patients admitted to Juntendo University Hospital (Tokyo, Japan) with intracerebral hemorrhage between January 1, 2016 and April 30, 2020. Clinical characteristics including serum omega-3 polyunsaturated fatty acid levels were compared between patients developing intracerebral hemorrhage during the period from January 1, 2016 to February 29, 2020, and the subsequent COVID-19 pandemic period (March 1 to April 30, 2020). Clinical characteristics independently related to intracerebral hemorrhage during the COVID-19 pandemic were analyzed by comparing these two cohorts of intracerebral hemorrhage patients in different periods.

Results

A total of 103 patients (age, 67.0 ± 13.9 years; 67 males) with intracerebral hemorrhage were enrolled. Intracerebral hemorrhage developed in 91 patients before and 12 patients during the COVID-19 pandemic. Monthly averages of intracerebral hemorrhage patients admitted to our hospital during and before the COVID-19 pandemic were 6 and 1.82, respectively. Serum eicosapentaenoic acid levels were significantly lower in intracerebral hemorrhage patients during the COVID-19 pandemic than before (31.87 ± 12.93 μg/ml vs. 63.74 ± 43.29 μg/ml, p = 0.007). Multiple logistic regression analysis showed that, compared to before the COVID-19 pandemic, dyslipidemia (odds ratio 0.163, 95% confidence interval 0.031–0.852; p = 0.032) and eicosapentaenoic acid levels (odds ratio 0.947, 95% confidence interval 0.901–0.994; p = 0.029) were associated with intracerebral hemorrhage during the COVID-19 pandemic.

Conclusions

From our preliminary results, low eicosapentaenoic acid levels were linked with intracerebral hemorrhage during the COVID-19 pandemic. Low levels of eicosapentaenoic acid might be an endogenous surrogate marker for intracerebral hemorrhage during the COVID-19 pandemic.

Poelman MP, Gillebaart M, Schlinkert C, Dijkstra SC, Derksen E, Mensink F, et al. Eating behavior and food purchases during the COVID-19 lockdown: a cross-sectional study among adults in the Netherlands. Appetite. 2020;157:105002. https://doi.org/10.1016/j.appet.2020.105002.CrossRefPubMedPubMedCentral

Sidor A, Rzymski P. Dietary choices and habits during COVID-19 lockdown: experience from Poland. Nutrients. 2020;12:6. https://doi.org/10.3390/nu12061657.CrossRef

van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–76. https://doi.org/10.1016/S1474-4422(09)70340-0.CrossRefPubMed

Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060–5. https://doi.org/10.1161/01.STR.0000080678.09344.8D.CrossRefPubMed

Lammie GA, Lindley R, Keir S, Wiggam MI. Stress-related primary intracerebral hemorrhage: autopsy clues to underlying mechanism. Stroke. 2000;31(6):1426–8. https://doi.org/10.1161/01.str.31.6.1426.CrossRefPubMed

Muto M, Ezaki O. High dietary saturated fat is associated with a low risk of intracerebral hemorrhage and ischemic stroke in Japanese but not in non-Japanese: a review and Meta-analysis of prospective cohort studies. J Atheroscler Thromb. 2018;25(5):375–92. https://doi.org/10.5551/jat.41632.CrossRefPubMedPubMedCentral

Rothstein A, Oldridge O, Schwennesen H, Do D, Cucchiara BL. Acute cerebrovascular events in hospitalized COVID-19 patients. Stroke. 2020;51(9):e219–e22. https://doi.org/10.1161/STROKEAHA.120.030995.CrossRefPubMed

Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002–11. https://doi.org/10.1161/STROKEAHA.120.030335.CrossRefPubMed

Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: clinical characteristics from a case series. Brain Behav Immun. 2020;88:940–4. https://doi.org/10.1016/j.bbi.2020.06.005.CrossRefPubMedPubMedCentral

10.

Melmed KR, Cao M, Dogra S, Zhang R, Yaghi S, Lewis A, et al. Risk factors for intracerebral hemorrhage in patients with COVID-19. J Thromb Thrombolysis. 2020. https://doi.org/10.1007/s11239-020-02288-0.

11.

Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. https://doi.org/10.1016/j.nmni.2020.100669.CrossRefPubMedPubMedCentral

12.

Muhammad S, Petridis A, Cornelius JF, Hanggi D. Letter to editor: severe brain haemorrhage and concomitant COVID-19 infection: a neurovascular complication of COVID-19. Brain Behav Immun. 2020;87:150–1. https://doi.org/10.1016/j.bbi.2020.05.015.CrossRefPubMedPubMedCentral

13.

Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan collaborative cohort study for evaluation of Cancer risk) study. J Am Coll Cardiol. 2008;52(12):988–96. https://doi.org/10.1016/j.jacc.2008.06.018.CrossRefPubMed

14.

Takata Y, Zhang X, Li H, Gao YT, Yang G, Gao J, et al. Fish intake and risks of total and cause-specific mortality in 2 population-based cohort studies of 134,296 men and women. Am J Epidemiol. 2013;178(1):46–57. https://doi.org/10.1093/aje/kws584.CrossRefPubMedPubMedCentral

15.

Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan public health center-based (JPHC) study cohort I. Circulation. 2006;113(2):195–202. https://doi.org/10.1161/CIRCULATIONAHA.105.581355.CrossRefPubMed

16.

Domei T, Yokoi H, Kuramitsu S, Soga Y, Arita T, Ando K, et al. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ J. 2012;76(2):423–9. https://doi.org/10.1253/circj.cj-11-0941.CrossRefPubMed

17.

Hara M, Sakata Y, Nakatani D, Suna S, Usami M, Matsumoto S, et al. Low levels of serum n-3 polyunsaturated fatty acids are associated with worse heart failure-free survival in patients after acute myocardial infarction. Circ J. 2013;77(1):153–62. https://doi.org/10.1253/circj.cj-12-0875.CrossRefPubMed

18.

Hishikari K, Kimura S, Yamakami Y, Kojima K, Sagawa Y, Otani H, et al. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions. Atherosclerosis. 2015;239(2):583–8. https://doi.org/10.1016/j.atherosclerosis.2015.02.035.CrossRefPubMed

19.

Ueno Y, Tanaka R, Yamashiro K, Miyamoto N, Hira K, Kurita N, et al. Age stratification and impact of Eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid ratios in ischemic stroke patients. J Atheroscler Thromb. 2018;25(7):593–605. https://doi.org/10.5551/jat.40691.CrossRefPubMedPubMedCentral

20.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. https://doi.org/10.1056/NEJMoa2002032.CrossRefPubMed

21.

Kwak R, Kadoya S, Suzuki T. Factors affecting the prognosis in thalamic hemorrhage. Stroke. 1983;14(4):493–500. https://doi.org/10.1161/01.str.14.4.493.CrossRefPubMed

22.

Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–6. https://doi.org/10.2214/ajr.149.2.351.CrossRefPubMed

23.

Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13. https://doi.org/10.1016/j.trsl.2020.04.007.CrossRefPubMedPubMedCentral

24.

Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke. 2020. https://doi.org/10.1177/1747493020972922.

25.

Wang H, Tang X, Fan H, Luo Y, Song Y, Xu Y, et al. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients. Aging (Albany NY). 2020;12(11):10022–34. https://doi.org/10.18632/aging.103335.CrossRef

26.

Chodkiewicz J, Talarowska M, Miniszewska J, Nawrocka N, Bilinski P. Alcohol consumption reported during the COVID-19 pandemic: the initial stage. Int J Environ Res Public Health. 2020;17:13. https://doi.org/10.3390/ijerph17134677.CrossRef

27.

Newby JM, O'Moore K, Tang S, Christensen H, Faasse K. Acute mental health responses during the COVID-19 pandemic in Australia. PLoS One. 2020;15(7):e0236562. https://doi.org/10.1371/journal.pone.0236562.CrossRefPubMedPubMedCentral

28.

Schneck MJ. Is psychological stress a risk factor for cerebrovascular disease? Neuroepidemiology. 1997;16(4):174–9. https://doi.org/10.1159/000109684.CrossRefPubMed

29.

Jackson CA, Sudlow CLM, Mishra GD. Psychological distress and risk of myocardial infarction and stroke in the 45 and up study. Circ Cardiovasc Qual Outcomes. 2018;11(9):e004500. https://doi.org/10.1161/CIRCOUTCOMES.117.004500.CrossRefPubMed

30.

Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected code stroke: Hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke. 2020;51(6):1891–5. https://doi.org/10.1161/STROKEAHA.120.029838.CrossRefPubMedPubMedCentral

31.

Uchino K, Kolikonda MK, Brown D, Kovi S, Collins D, Khawaja Z, et al. Decline in stroke presentations during COVID-19 surge. Stroke. 2020;51(8):2544–7. https://doi.org/10.1161/STROKEAHA.120.030331.CrossRefPubMed

32.

Miyata J, Arita M. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int. 2015;64(1):27–34. https://doi.org/10.1016/j.alit.2014.08.003.CrossRefPubMed

33.

Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand. 1980;208(5):401–6.PubMed

34.

Larsson SC, Orsini N, Wolk A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. Eur J Epidemiol. 2012;27(12):895–901. https://doi.org/10.1007/s10654-012-9748-9.CrossRefPubMed

35.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22. https://doi.org/10.1056/NEJMoa1812792.CrossRefPubMed

36.

Tanaka K, Ishikawa Y, Yokoyama M, Origasa H, Matsuzaki M, Saito Y, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke. 2008;39(7):2052–8. https://doi.org/10.1161/STROKEAHA.107.509455.CrossRefPubMed

37.

Yanagisawa N, Shimada K, Miyazaki T, Kume A, Kitamura Y, Ichikawa R, et al. Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb. 2010;17(3):285–94. https://doi.org/10.5551/jat.2618.CrossRefPubMed

38.

Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Doi M, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki prefectural health study. Circulation. 2009;119(16):2136–45. https://doi.org/10.1161/CIRCULATIONAHA.108.795666.CrossRefPubMed

Title: Association of blood eicosapentaenoic acid levels with intracerebral hemorrhage during the COVID-19 pandemic: preliminary experience from a single-center in Japan
Authors: Kenichiro Hira
Yuji Ueno
Nobukazu Miyamoto
Sho Nakajima
Chikage Kijima
Nobutaka Hattori
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Stroke
Dyslipidemia
COVID-19
Published in: BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-022-02657-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Association of blood eicosapentaenoic acid levels with intracerebral hemorrhage during the COVID-19 pandemic: preliminary experience from a single-center in Japan

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

HSP90 facilitates stemness and enhances glycolysis in glioma cells

Comparison of the effects of different doses of Glucocorticoids on distinct subtypes of Guillain-Barré syndrome in Southern China

A predictive model for postoperative progressive haemorrhagic injury in traumatic brain injuries

Correction: Palliative sedation in amyotrophic lateral sclerosis: results of a nationwide survey among neurologists and palliative care practitioners in Germany

A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol

Detrimental effect of increased blood pressure variability on clinical outcome in acute ischemic stroke treated with reperfusion therapy: a case control study